Early Progressing Follicular Lymphoma Danielle WallaceCarla Casulo Lymphomas (T Hilal, Section Editor) 19 November 2021 Article: 149
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy Alexandra LainéTravis T. SimsRobert L. Coleman Gynecologic Cancers (J Brown and RW Naumann, Section Editors) 09 November 2021 Article: 148
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient? Ernesto RossiMelissa BersanelliPaolo Andrea Zucali Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) Open access 08 November 2021 Article: 147
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis Shebin ShajiCharlotte SmithPatrice Forget Anesthesiology and Critical Care (JP Cata, Section Editor) Open access 08 November 2021 Article: 146
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine? Adi DavidDavid HausnerMoshe Frenkel Integrative Care (C Lammersfeld, Section Editor) 07 November 2021 Article: 145
Current Role of Functional Imaging in the Management of Lymphoma Bruce D. ChesonMichel Meignan Lymphomas (T Hilal, Section Editor) 04 November 2021 Article: 144
New Directions in Imaging Neuroendocrine Neoplasms Julie RefardtJohannes HoflandEmanuel Christ Neuroendocrine Neoplasms (NS Reed, Section Editor) Open access 04 November 2021 Article: 143
Is Myelodysplasia a Consequence of Normal Aging? Sonja HeiblReinhard StauderMichael Pfeilstöcker Geriatric Oncology (L Balducci, Section Editor) Open access 04 November 2021 Article: 142
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities Rita HleihelAbdou AkkoucheHiba El Hajj Lymphomas (T Hilal, Section Editor) 04 November 2021 Article: 141
Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker? Mahendra NaidooOliver PierceyJeanne Tie Gastrointestinal Cancers (J Meyer, Section Editor) 04 November 2021 Article: 140
New Treatments for Recurrent Uterine Cancer Michael D. ToboniMatthew A. Powell Gynecologic Cancers (J Brown and RW Naumann, Section Editors) 04 November 2021 Article: 139
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients Pier Francesco FerrucciMarko LensEmilia Cocorocchio Melanoma (RJ Sullivan, Section Editor) 04 November 2021 Article: 138
A New Generation of Vaccines in the Age of Immunotherapy Alfredo AddeoAlex FriedlaenderChristian Rolfo Lung Cancer (H Borghaei, Section Editor) 04 November 2021 Article: 137
The Role and Impact of Minimal Residual Disease in NSCLC Daniele FrisoneAlex FriedlaenderAlfredo Addeo Lung Cancer (H Borghaei, Section Editor) Open access 04 November 2021 Article: 136
